Healthcare in Singapore or the Singapore healthcare system is under the purview of the Ministry of Health of the Government of Singapore. It mainly consists of a government-run publicly funded universal healthcare system as well as a significant private healthcare sector. Financing of healthcare costs is done through a mixture of direct government subsidies, compulsory comprehensive savings, a national healthcare insurance, and cost sharing.
The Singaporean public health insurance system is based on programs run by the Central Provident Fund, primarily Medisave, a mandatory medical savings account scheme. All working citizens and permanent residents are obligated to set aside a portion of their income into Medisave accounts, which they can draw upon to pay their own medical bills and those of their immediate family. The Central Provident Fund also manages the MediShield and MediFund insurance schemes, which cover people with insufficient savings or those who have depleted their savings. In addition, the government provides subsidies for the medical expenses of citizens and permanent residents who receive treatment in public hospitals.
Singapore has an efficient and widespread system of healthcare by global standards. In 2000, Singapore was ranked 6th in the World Health Organization's ranking of the world's health systems. Bloomberg ranked Singapore's healthcare system the most efficient in the world in 2014. The Economist Intelligence Unit placed Singapore 2nd out of 166 countries for health-care outcomes. Bloomberg Global Health Index of 163 countries ranked Singapore the 4th healthiest country in the world and first in Asia.
As of 2019, Singaporeans have the world's longest life expectancy, 84.8 years at birth. Women can expect to live an average of 87.6 years with 75.8 years in good health, and men with a life expectancy at 81.9 years with 72.5 years in good health. In 2020, the Bloomberg Health-Efficiency Index, which tracks life expectancy and medical spending, ranked Singapore 1st in the world for the most efficient healthcare. In light of the COVID-19 pandemic, the results of that year also include the impact of COVID-19 on mortality and gross domestic product in 57 of the world's largest economies.
According to global consulting firm Towers Watson (now Willis Towers Watson), Singapore has "one of the most successful healthcare systems in the world, in terms of both efficiency in financing and the results achieved in community health outcomes". This has been attributed to a combination of a strong reliance on medical savings accounts, cost sharing, and government regulation. The government regularly adjusts policies to actively regulate "the supply and prices of healthcare services in the country" in an attempt to keep costs in check. However, for the most part, the government does not directly regulate the costs of private medical care unless necessary. These costs are largely subject to market forces, and vary enormously within the private sector, depending on the medical specialty and service provided.
Furthermore, Towers Watson states that the specific features of the Singapore healthcare system are unique, and have been described as a "Very difficult system to replicate in many other countries." Many Singaporeans also have supplemental private health insurance (often provided by employers) for services that may not be covered by the government's programmes, such as cosmetic dentistry and some prescription drugs.